CIK: 0001668029 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Sep 17, 2021
Total Value ($000): $8,849 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABG ACQUISITION CORP I | 501,300 | $4,913 | 55.5% | $9.89 | — | CL A SHS | G00496102 |
| AVIR | ATEA PHARMACEUTICALS INC | 143,867 | $3,090 | 34.9% | $32.23 | -6.8% | COM | 04683R106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $780 | 8.8% | $7.87 | — | COM | 00773J103 |
| — | DIFFUSION PHARMACEUTICALS IN | 89,848 | $66 | 0.7% | $0.79 | — | COM PAR | 253748305 |